Zerbaxa (2020-12-16)
- Starting date:
- December 16, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-74593
Last updated:
2020-12-17
Summary
-
Product:
Zerbaxa
Reason
Product sterility may be compromised in affected lots
Depth of distribution
Wholesalers, Retailers, Healthcare establishments, Healthcare practitioners
Affected products
Zerbaxa
DIN, NPN, DIN-HIM
DIN 02446901
Dosage form
Powder For Solution
Strength
Ceftolozane (Ceftolozane Sulfate) 1 G / VIAL
Tazobactam (Tazobactam Sodium) 0.5 G / VIAL
Lot or serial number
SP1561A
SP1617A
SP1637A
Companies
- Recalling Firm
-
Merck Canada Inc.
16750 Transcanada Hwy
Kirkland
H9H 4M7
Quebec
CANADA
- Marketing Authorization Holder
-
Merck Canada Inc.
16750 Transcanada Hwy
Kirkland
H9H 4M7
Quebec
CANADA